Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Post-marketing Study on the Safety and Efficacy of Dotarem® (SECURE Study)

NCT01523873 is registered in ClinicalTrials.gov with Guerbet as lead sponsor.

NCT NCT01523873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01523873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Post-marketing Study on the Safety and Efficacy of Dotarem® (SECURE Study)
Lead sponsor
Guerbet
Phase
Observational
Overall status
Completed
Start date
November 30, 2008
Completion date
July 31, 2013
Enrollment
35,921 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

general safety profile of dotarem